These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22115520)

  • 1. Correlations between cortical and subcortical tau pathology.
    Attems J; Thomas A; Jellinger K
    Neuropathol Appl Neurobiol; 2012 Oct; 38(6):582-90. PubMed ID: 22115520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.
    Tsuboi Y; Wszolek ZK; Graff-Radford NR; Cookson N; Dickson DW
    Neuropathol Appl Neurobiol; 2003 Oct; 29(5):503-10. PubMed ID: 14507342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
    Attems J; Jellinger KA
    Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-localization of tau and alpha-synuclein in the olfactory bulb in Alzheimer's disease with amygdala Lewy bodies.
    Fujishiro H; Tsuboi Y; Lin WL; Uchikado H; Dickson DW
    Acta Neuropathol; 2008 Jul; 116(1):17-24. PubMed ID: 18446351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies.
    Ishizawa T; Mattila P; Davies P; Wang D; Dickson DW
    J Neuropathol Exp Neurol; 2003 Apr; 62(4):389-97. PubMed ID: 12722831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau and alpha-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs.
    Attems J; Quass M; Jellinger KA
    Acta Neuropathol; 2007 Jan; 113(1):53-62. PubMed ID: 17031655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lewy body variant of Alzheimer's disease or cerebral type lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem.
    Yokota O; Tsuchiya K; Uchihara T; Ujike H; Terada S; Takahashi M; Kimura Y; Ishizu H; Akiyama H; Kuroda S
    Neuropathology; 2007 Feb; 27(1):21-35. PubMed ID: 17319280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lewy bodies in progressive supranuclear palsy represent an independent disease process.
    Uchikado H; DelleDonne A; Ahmed Z; Dickson DW
    J Neuropathol Exp Neurol; 2006 Apr; 65(4):387-95. PubMed ID: 16691119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases.
    Pletnikova O; West N; Lee MK; Rudow GL; Skolasky RL; Dawson TM; Marsh L; Troncoso JC
    Neurobiol Aging; 2005; 26(8):1183-92. PubMed ID: 15917102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olfactory involvement in aging and Alzheimer's disease: an autopsy study.
    Attems J; Lintner F; Jellinger KA
    J Alzheimers Dis; 2005 Apr; 7(2):149-57; discussion 173-80. PubMed ID: 15851853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between subcortical tau pathology and Alzheimer's disease.
    Attems J; Thal DR; Jellinger KA
    Biochem Soc Trans; 2012 Aug; 40(4):711-5. PubMed ID: 22817721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia.
    Fujishiro H; Iseki E; Higashi S; Kasanuki K; Murayama N; Togo T; Katsuse O; Uchikado H; Aoki N; Kosaka K; Arai H; Sato K
    Neurosci Lett; 2010 Dec; 486(1):19-23. PubMed ID: 20851165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort.
    Zaccai J; Brayne C; McKeith I; Matthews F; Ince PG;
    Neurology; 2008 Mar; 70(13):1042-8. PubMed ID: 18362284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lewy body-related alpha-synucleinopathy in the aged human brain.
    Jellinger KA
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain stem pathology in Parkinson's disease: an evaluation of the Braak staging model.
    Kingsbury AE; Bandopadhyay R; Silveira-Moriyama L; Ayling H; Kallis C; Sterlacci W; Maeir H; Poewe W; Lees AJ
    Mov Disord; 2010 Nov; 25(15):2508-15. PubMed ID: 20818670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative neuropathology: an update on automated methodologies and implications for large scale cohorts.
    Walker L; McAleese KE; Johnson M; Khundakar AA; Erskine D; Thomas AJ; McKeith IG; Attems J
    J Neural Transm (Vienna); 2017 Jun; 124(6):671-683. PubMed ID: 28265813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An experimental model of Braak's pretangle proposal for the origin of Alzheimer's disease: the role of locus coeruleus in early symptom development.
    Ghosh A; Torraville SE; Mukherjee B; Walling SG; Martin GM; Harley CW; Yuan Q
    Alzheimers Res Ther; 2019 Jul; 11(1):59. PubMed ID: 31266535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dementia with Lewy bodies showing advanced Lewy pathology but minimal Alzheimer pathology--Lewy pathology causes neuronal loss inducing progressive dementia.
    Uchikado H; Iseki E; Tsuchiya K; Togo T; Katsuse O; Uéda K; Kato M; Kosaka K
    Clin Neuropathol; 2002; 21(6):269-77. PubMed ID: 12489676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
    Compta Y; Parkkinen L; O'Sullivan SS; Vandrovcova J; Holton JL; Collins C; Lashley T; Kallis C; Williams DR; de Silva R; Lees AJ; Revesz T
    Brain; 2011 May; 134(Pt 5):1493-1505. PubMed ID: 21596773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.